vling@tfri.ca Dr. Victor Ling is the founding Scientific Director of TFRI. He is an authority on multi-drug resistance in cancer, and is well-known for his discovery of P-glycoprotein, the first molecule identified to be responsible for drug resistance. Most recently, Dr. Ling was the Vice President of Discovery Research at the BC Cancer Agency. Dr. Ling will provide overall leadership to TFRI, the development of translational research projects, relationships with stakeholders, and TFRI communications. |
sherst@tfri.ca Stephen Herst is Chief Operating Officer. Stephen was previously Director of Research Development at the BC Cancer Research Centre, and held executive positions at two successful Networks of Centres of Excellence - the Canadian Genetic Diseases Network and the Protein Engineering Network of Centres of Excellence. He was part of the team that launched the Canadian Bioinformatics Workshops, and was involved in the early development of the Human Genome Organization in Europe. More recently, Stephen has been a project manager for a number of large-scale genomics research programs at the BC Cancer Agency. |
kcurwin@tfri.ca Kelly Curwin is Chief Communications Officer. She holds an MBA in Communications Management and Public Relations from Royal Roads University (Victoria) and an Honours Bachelor of Journalism degree from Carleton University (Ottawa). As a communications consultant, Kelly conducted work for the Fraser Health Authority, Trillium Health Centre in Mississauga, the University of Waterloo and KCI (formerly Ketchum Canada Inc.) in Toronto. She served in public relations at McMaster University for more than a decade and is a former editor of Nunavut's Nunatsiaq News, based in Iqaluit. An award-winning writer and editor, she is a former volunteer for the Wellwood Resource Centre in Hamilton. |
Additional members of the TFRI headquarters team will be added in the near future.
